For CVS, the benefits to purchasing Target’s pharmacy business outweigh the cost of slowing share buybacks.
WSJ.com: Heard on the Street, Wall Street Journal: Markets: Heard on the Street
Mon, 06/15/2015 - 10:41am
For CVS, the benefits to purchasing Target’s pharmacy business outweigh the cost of slowing share buybacks.